Mayo Clinic

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Mayo Clinic sits in the top decile of US sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count).

2,844 total trials 544 currently recruiting 1816 completed early-phase tilt top decile by trial count

Mayo Clinic: 2,844 sponsored US clinical trials, 544 recruiting.

Mayo Clinic sponsors 2,844 registered US clinical trials on ClinicalTrials.gov, 544 of them currently recruiting, and 1,816 completed. 252 of these trials are in Phase 3-4 (later-stage) and 821 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 36 trials.

Top-decile sponsor footprint

Mayo Clinic ranks in the top decile of sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

2,844 total, page 45 of 57

COMPLETED NA

Telecoaching Plus a Portion Control Device for Weight Management in the Primary Care Setting

NCT02373878
TERMINATED Phase 4

Prospective Randomized Trial Comparing Robotic Versus Open Radical Prostatectomy

NCT01365143
COMPLETED NA

Physical Activity Coaching in Chronic Obstructive Pulmonary Disease (COPD)

NCT01349608
COMPLETED NA

Activity Monitoring and Counseling in a Geriatric Population

NCT01502007
COMPLETED NA

"Effect of High Fat and High Glycemic Diets

NCT01494935
COMPLETED Phase 4

Pregabalin on Colonic Motor and Sensory Function in Constipation Predominant Irritable Bowel Syndrome

NCT01331213
COMPLETED

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

NCT00667121
COMPLETED NA

Scrambler Therapy in Treating Chronic Pain in Patients With Rash From Varicella Zoster Virus Infection

NCT01347736
COMPLETED

Scrambler Therapy in Treating Pain and Peripheral Neuropathy in Patients Previously Treated With Chemotherapy

NCT01347723
COMPLETED NA

Blood Pressure Telemonitoring and Goal Blood Pressure in Diabetes

NCT01300338
COMPLETED NA

Vagal Nerve Stimulation and Glucose Metabolism

NCT01117311
COMPLETED

Longitudinal Study of Cognition With Niemann-Pick Disease, Type C

NCT01899950
TERMINATED Phase 2

Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy

NCT01200602
TERMINATED NA

Continuous Positive Airway Pressure and Cardiometabolic Risk

NCT01403194
COMPLETED NA

Comparative Effectiveness of Endoscopic Assessment of Gastroesophageal Reflux and Barretts Esophagus

NCT01288612
COMPLETED Phase 2

MC5-A Scrambler Therapy in Reducing Peripheral Neuropathy Caused by Chemotherapy

NCT01290224
COMPLETED NA

Myocardial Blood Flow by PET and N-13 Ammonia During Regadenoson vs Adenosine Stress

NCT01370265
TERMINATED NA

WRx Distal Radius Wrist Fracture Study

NCT01293227
TERMINATED

High Definition White Light Endoscopy and Narrow Band Imaging for the Assessment of Barrett's Disease After Endoscopic Therapy

NCT01360801
TERMINATED

Endotracheal Cardiac Output Monitor (ECOM) for Patients Undergoing Liver Transplantation

NCT01299441
TERMINATED Phase 4

Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery

NCT01195103
COMPLETED Phase 2

Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

NCT01261247
COMPLETED Phase 1

Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma

NCT01075321
COMPLETED Phase 2

Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

NCT01328535
COMPLETED NA

Device-guided Breathing for Shortness of Breath in COPD

NCT01286181
COMPLETED Phase 1

Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia

NCT01269385
COMPLETED

Early Mobilization of Ischemic Stroke Patients Within 24-hours After Intravenous-Tissue Plasminogen Activator (IV-tPA)

NCT01331200
COMPLETED

A Comparison of Infection Rates Between Two Surgical Sites

NCT01263262
COMPLETED

Colorectal Polyp Discrimination Using High-Definition Narrow Band Imaging

NCT01354873
COMPLETED NA

Study to Test Use of a Decision Aid in a Clinical Visit to Help Patients Choose a Diabetes Medication

NCT01293578
COMPLETED

Microvesicle Production After Acute Trauma and Its Clinical Impact on Venothromboembolism

NCT01264458
COMPLETED Phase 1

A Pilot Clinical Trial to Evaluate the Effects of Acupuncture in Patients on Prolonged Mechanical Ventilation

NCT01621139
TERMINATED Phase 3

Varenicline and Alcohol in Inpatient Addictions Program (IAP)

NCT01169610
COMPLETED

Impact of Muscle Insulin Resistance on the Pathogenesis of Non Alcoholic Steatohepatitis

NCT01324414
COMPLETED Phase 1

Safety of Synbiotics as Adjuvant to Influenza Vaccine in Elderly

NCT01304771
COMPLETED NA

Self Help Intervention to Decrease Stress

NCT01242865
COMPLETED NA

A Comparison of Ketofol (Ketamine and Propofol Admixture) Versus Propofol as Induction Agents on Hemodynamic Parameters

NCT01065350
COMPLETED NA

Carbon-13 (13C)-Spirulina Platensis Gastric Emptying Breath Test (GEBT)

NCT01248221
COMPLETED Phase 2

Vitamin D Supplementation in Breastfeeding Women

NCT01240265
COMPLETED

The Role of the Fujinon Intelligent Chromo Endoscopy (FICE™) in Barrett's Esophagus

NCT01084629
COMPLETED Early Phase 1

Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma

NCT01239875
COMPLETED

Histology of Functional Density in Postmenopausal Breast

NCT01240278
COMPLETED Phase 1

Code Status Video in the Intensive Care Unit: Video Assisted Patient Education

NCT01610076
TERMINATED Phase 2

Teriparatide for Postsurgical Hypoparathyroidism

NCT01171690
COMPLETED NA

Paired Marrow Aspirations to Assess Assays in Sensitized Renal Allograft Recipients

NCT01150487
COMPLETED NA

Abdominal Compression in Orthostatic Hypotension

NCT01223391
COMPLETED NA

Measuring the Effect of Chair Massage on Stress Related Symptoms for Nurses

NCT01504763
COMPLETED Phase 4

Adjustable Gastric Banding and Its Effects on Postprandial Glucose Metabolism Independent of Weight Loss

NCT01094054
COMPLETED

Magnetic Resonance Elastography (MRE) of Uterine Fibroids

NCT01229826
COMPLETED Phase 2

Evaluation of SAMe for Hot Flashes

NCT01140646
← Previous Page 45 of 57 Next →

Phase Distribution

PhaseTrial count
Phase 1 435
Phase 2 386
Phase 3 86
Phase 4 166

Therapeutic Areas

Healthy 36
Malignant Solid Neoplasm 35
Obesity 31
Breast Cancer 25
Breast Carcinoma 21
Hematopoietic and Lymphatic System Neoplasm 20
Hematopoietic and Lymphoid System Neoplasm 12
Heart Failure 11
Cancer 11
Prostate Carcinoma 9

What is open in the Mayo Clinic pipeline

544 recruiting of 2,844 indexed (19% open); 1,816 completed (64%).

Phase mix: 252 late (III/IV) vs 821 early (I/II) (early-phase heavy).

Top condition: Healthy (36 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Related

Compare saved trials side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.